Twist1 Is Required for the Development of UVB-Induced Squamous Cell Carcinoma

    March 2021 in “ Molecular Carcinogenesis
    Fernando Eguiarte‐Solomon, Nicholas Blazanin, Okkyung Rho, Steve Carbajal, Dean W. Felsher, Phuoc T. Tran, John DiGiovanni
    TLDR Twist1 is crucial for UVB-induced skin cancer development.
    The study investigated the role of the transcription factor Twist1 in UVB-induced skin carcinogenesis. Using K5.Cre × Twist1flox/flox mice, researchers found that the deletion of Twist1 in basal keratinocytes significantly reduced UVB-induced epidermal hyperproliferation and skin carcinogenesis. The absence of Twist1 led to increased keratinocyte differentiation, as evidenced by the induction of differentiation markers such as TG1, K1, OVOL1, loricrin, and filaggrin. Conversely, overexpression of Twist1 suppressed differentiation. The study also showed that Twist1 deletion resulted in the loss of hair follicle stem/progenitor markers. These findings suggested that Twist1 played a crucial role in maintaining the balance between proliferation and differentiation in keratinocytes and could be a potential target for preventing cutaneous squamous cell carcinoma.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 77 results

      community Is DUT better or worse than FIN?

      in Finasteride/Dutasteride  62 upvotes 2 years ago
      The conversation discusses the effectiveness of Dutasteride (DUT) and Finasteride (FIN) for hair loss. Users share varied experiences, with some finding DUT more effective and others experiencing side effects or no change, highlighting that individual responses can vary.

      community Twist1 Group Buy: Yes it’s that easy

      in Research/Science  39 upvotes 3 years ago
      A group buy for testing a compound targeting Twist1 protein as a potential hair loss treatment. Inhibiting Twist1, which keeps hair follicles in growth phase, may prevent hair loss with minimal side effects.

      community Fevipiprant 2019!

       16 upvotes 9 years ago
      The conversation discusses Fevipiprant, an asthma drug that may block CRTH2 and potentially stop male pattern baldness (MPB) without inhibiting DHT. It also mentions the use of finasteride and dutasteride for hair loss.

    Similar Research

    5 / 525 results